High materiality8/10
DexCom (DXCM) PT Raised to $95 at UBS as Data Impress at ADA
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
UBS raises DexCom (DXCM) target to $95; current price $78.42.
- Target $95
- Posted price $78.42
- Analyst firm UBS
Key facts
- 01
Target: $95
- 02
Posted price: $78.42
- 03
Analyst firm: UBS
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.